MedTrace Logo

Blind Needling Accuracy in Lumbar Muscles

NCT07074249 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-09-19

No results posted yet for this study

Summary

The aim of this study is to evaluate the accuracy of blinded invasive interventions (dry needling) on the deep paraspinal muscles of the lumbar region (iliocostalis lumborum, longissimus thoracis, and multifidus) to reach the anatomical target. The accuracy of the interventions will be evaluated observationally with ultrasonography after the procedure.

Conditions

  • Dry Needling Lumbar Paraspinal Muscles

Interventions

PROCEDURE

"Anatomical Accuracy of Blind Dry Needling Procedures on the Lumbar Paraspinal Muscles: An Ultrasonography-Assisted Observational Study"

* All interventions will be performed by a physical medicine and rehabilitation specialist with clinical experience. * Targeted muscles: * \*Iliocostalis lumborum (ICL)\* * \*Longissimus thoracis (LT)\* * \*Multifidus (M)\* * Interventions will be performed from the right side, between the L2-L5 levels. * A total of \*three different dry needling applications\* will be performed for these three muscles for each participant.

PROCEDURE

"Anatomical Accuracy of Blind Dry Needling Procedures on the Lumbar Paraspinal Muscles: An Ultrasonography-Assisted Observational Study"

\*All interventions will be performed by a physical medicine and rehabilitation specialist with clinical experience. \* Targeted muscles: \* \*Iliocostalis lumborum (ICL)\* \* \*Longissimus thoracis (LT)\* \* \*Multifidus (M)\* \* Interventions will be performed from the right side, between the L2-L5 levels. \* A total of \*three different dry needling applications\* will be performed for these three muscles for each participant. After each intervention, the needle tip position will be evaluated by a second specialist with \*high-resolution linear probe ultrasound\*.

Sponsors & Collaborators

  • Erzurum Regional Training & Research Hospital

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-28
Primary Completion
2025-09-30
Completion
2025-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07074249 on ClinicalTrials.gov